Amyloid localized to tenosynovium at carpal tunnel release. Natural history of 124 cases.
One hundred fifty-two patients with amyloid in the tenosynovium who had carpal tunnel release were identified. Twenty-eight patients were excluded because of systemic amyloidosis: primary systemic amyloidosis (AL) in 24, secondary amyloidosis (AA) in 3, and familial amyloidosis (AF) in 1. The remaining 124 patients (82%) had carpal tunnel syndrome with local deposition of amyloid and no evidence of systemic amyloidosis. Median survival of the 124 patients from diagnosis of amyloidosis was 12 years. Only two patients had systemic amyloidosis develop--9 and 10 years after recognition of tenosynovial amyloid. Of particular interest were 12 patients who had an M-protein in the serum or urine. None of the 12 patients have had evidence of systemic amyloidosis or multiple myeloma during the median follow-up of 14 years. The authors conclude that amyloid may be localized to the tenosynovium and that systemic amyloidosis rarely develops during long-term follow-up.
Kyle
R A
RA
Department of Orthopedics, Mayo Clinic, Rochester, Minnesota 55905.
Eilers
S G
SG
Linscheid
R L
RL
Gaffey
T A
TA
D000368:Aged; D000369:Aged, 80 and over; D000682:Amyloid / Q000032:analysis*; D002349:Carpal Tunnel Syndrome / Q000378:metabolism / Q000473:pathology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007075:Immunoglobulin M / Q000032:analysis / Q000652:urine; D008022:Ligaments / Q000032:analysis*; D008297:Male; D008875:Middle Aged; D013583:Synovial Membrane / Q000032:analysis*
D000682:Amyloid; D007075:Immunoglobulin M